Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium, 67490 [2022-24273]

Download as PDF 67490 Federal Register / Vol. 87, No. 215 / Tuesday, November 8, 2022 / Notices Register pursuant to section 6(b) of the Act on August 1, 2022 (97 FR 47005). Register pursuant to Section 6(b) of the Act on August 30, 2022 (87 FR 53005). Catherine Reilly, Counsel for Civil Operations, Antitrust Division. Catherine Reilly, Counsel for Civil Operations, Antitrust Division. [FR Doc. 2022–24262 Filed 11–7–22; 8:45 am] [FR Doc. 2022–24273 Filed 11–7–22; 8:45 am] BILLING CODE P BILLING CODE P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Antitrust Division Antitrust Division lotter on DSK11XQN23PROD with NOTICES1 Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical CBRN Defense Consortium Notice is hereby given that, on October 6, 2022, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Medical CBRN Defense Consortium (‘‘MCDC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Adaptive Phage Therapeutics, Inc., Gaithersburg, MD; Amentum Services, Inc., Germantown, MD; Benevira, Inc., New York, NY; Domenix Corporation, Chantilly, VA; International Business Machines Corporation, Yorktown Heights, NY; Rajant Corporation, Malvern, PA; SGSD Partners LLC, Washington, DC; The Washington University, Saint Louis, MO; and Zymeron Corporation, Durham, NC have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MCDC intends to file additional written notifications disclosing all changes in membership. On November 13, 2015, MCDC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on January 6, 2016 (81 FR 513). The last notification was filed with the Department on July 6, 2022. A notice was published in the Federal VerDate Sep<11>2014 18:33 Nov 07, 2022 Jkt 259001 Notice Pursuant to the National Cooperative Research and Production Act of 1993—Gap Year Association Notice is hereby given that on September 26, 2022, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Gap Year Association (GYA) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing additions or changes to its standards development activities. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, the 2023 Gap Year Program Standards have been ratified by GYA’s Standards and Accreditations Committee. On June 6, 2012, GYA filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on July 6, 2012 (77 FR 40085). The last notification was filed with the Department on January 17, 2018. A notice was published in the Federal Register pursuant to section 6(b) of the Act on February 12, 2018 (83 FR 6051). Catherine Reilly, Counsel for Civil Operations, Antitrust Division. [FR Doc. 2022–24251 Filed 11–7–22; 8:45 am] BILLING CODE 4410–11–P Notice Pursuant to the National Cooperative Research and Production Act of 1993—ODVA, Inc. Notice is hereby given that, on October 17, 2022, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), ODVA, Inc. (‘‘ODVA’’) has filed written notifications simultaneously with the Fmt 4703 [FR Doc. 2022–24270 Filed 11–7–22; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Notice Pursuant to the National Cooperative Research and Production Act of 1993—PXI Systems Alliance, Inc. Antitrust Division Frm 00055 Catherine Reilly, Counsel for Civil Operations, Antitrust Division. Antitrust Division DEPARTMENT OF JUSTICE PO 00000 Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, FIAtec GmbH, Magdeburg, GERMANY; Hermary, Coquitlam, BC, CANADA; plating electronic GmbH, Sexau, GERMANY; Kinova Robotics, Boisbriand, QC, CANADA; Converting Equipment International, Columbia Falls, MT; Encoder Products Company, Sagle, ID; and KYOWA ELECTRONIC INSTRUMENTS CO., LTD., Tokyo, JAPAN, have been added as parties to this venture. Also, Thorsis Technologies, Magdeburg, GERMANY; and YJS Co., Ltd., Bucheon City, Gyeonggi-Do, SOUTH KOREA, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and ODVA intends to file additional written notifications disclosing all changes in membership. On June 21, 1995, ODVA filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on February 15, 1996 (61 FR 6039). The last notification was filed with the Department on July 12, 2022. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on August 1, 2022 (87 FR 47004– 47005). Sfmt 4703 Notice is hereby given that, on October 18, 2022, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), PXI Systems Alliance, Inc. (‘‘PXI Systems’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its E:\FR\FM\08NON1.SGM 08NON1

Agencies

[Federal Register Volume 87, Number 215 (Tuesday, November 8, 2022)]
[Notices]
[Page 67490]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24273]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical CBRN Defense Consortium

    Notice is hereby given that, on October 6, 2022, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense 
Consortium (``MCDC'') has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
changes in its membership. The notifications were filed for the purpose 
of extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, Adaptive Phage Therapeutics, Inc., Gaithersburg, MD; 
Amentum Services, Inc., Germantown, MD; Benevira, Inc., New York, NY; 
Domenix Corporation, Chantilly, VA; International Business Machines 
Corporation, Yorktown Heights, NY; Rajant Corporation, Malvern, PA; 
SGSD Partners LLC, Washington, DC; The Washington University, Saint 
Louis, MO; and Zymeron Corporation, Durham, NC have been added as 
parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MCDC intends to file additional 
written notifications disclosing all changes in membership.
    On November 13, 2015, MCDC filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
January 6, 2016 (81 FR 513).
    The last notification was filed with the Department on July 6, 
2022. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on August 30, 2022 (87 FR 53005).

Catherine Reilly,
Counsel for Civil Operations, Antitrust Division.
[FR Doc. 2022-24273 Filed 11-7-22; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.